MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer

Up to 10% of women with a diagnosis of unilateral breast cancer have cancer in the contralateral breast, despite negative clinical and mammographic examinations. This study investigated the use of MRI examination of the contralateral breast in women with a diagnosis of unilateral breast cancer and n...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2007-03, Vol.356 (13), p.1295-1303
Hauptverfasser: Lehman, Constance D, Gatsonis, Constantine, Kuhl, Christiane K, Hendrick, R. Edward, Pisano, Etta D, Hanna, Lucy, Peacock, Sue, Smazal, Stanley F, Maki, Daniel D, Julian, Thomas B, DePeri, Elizabeth R, Bluemke, David A, Schnall, Mitchell D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1303
container_issue 13
container_start_page 1295
container_title The New England journal of medicine
container_volume 356
creator Lehman, Constance D
Gatsonis, Constantine
Kuhl, Christiane K
Hendrick, R. Edward
Pisano, Etta D
Hanna, Lucy
Peacock, Sue
Smazal, Stanley F
Maki, Daniel D
Julian, Thomas B
DePeri, Elizabeth R
Bluemke, David A
Schnall, Mitchell D
description Up to 10% of women with a diagnosis of unilateral breast cancer have cancer in the contralateral breast, despite negative clinical and mammographic examinations. This study investigated the use of MRI examination of the contralateral breast in women with a diagnosis of unilateral breast cancer and negative clinical and mammographic examinations. MRI detected occult cancer in the contralateral breast in about 3% of these women. All of the cancers were early stage, without evidence of spread to the lymph nodes or beyond. MRI detected occult cancer in the contralateral breast in about 3% of women with a diagnosis of unilateral breast cancer and negative clinical and mammographic examinations. A woman with unilateral breast cancer has an increased risk of having cancer in the contralateral breast. 1 – 6 In the 1990s, the role of mammography in improving the detection of contralateral cancers at the time of the initial diagnosis of breast cancer was firmly established; as compared with clinical breast examination alone, mammography resulted in a 1 to 3% increase in the number of cancers detected. 7 – 9 Despite normal findings on clinical and mammographic examination of the contralateral breast at the time of the initial breast-cancer diagnosis, however, contralateral cancer was subsequently detected in up to 10% of women. 1 , . . .
doi_str_mv 10.1056/NEJMoa065447
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70317021</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1246505991</sourcerecordid><originalsourceid>FETCH-LOGICAL-c504t-2a7f7fca843f4a1d74013810c4f6e49afdf7a291bd39c21e74155aee5c087643</originalsourceid><addsrcrecordid>eNpt0M9PFDEUwPGGYGRFb5xJY9STo_0105kjLqtiFk0ICeE0eXReZTYz7dJ2MPz3drNLMIYeXi-fvDZfQo44-8RZWX3-ufhx7oFVpVJ6j8x4KWWhFKv2yYwxURdKN_KAvIpxxfLhqnlJDriWjZCMzcj1-cUZXdzDMEHqvaPe0nSLdO5dCjBAwjzpl4AQE-0dvfIjOvqnT7f0Ag26NDzQ0x5-Ox-xe3RzcAbDa_LCwhDxze4-JJdfF5fz78Xy17ez-cmyMCVTqRCgrbYGaiWtAt5pxbisOTPKVqgasJ3VIBp-08nGCI5a8bIExNKwWldKHpIP27Xr4O8mjKkd-2hwGMChn2KrmeSaCZ7h2__gyk_B5a-1QuQcopIb9HGLTPAxBrTtOvQjhIeWs3aTu_03d-bHu53TzYjdE971zeD9DkA0MNiQ0_TxydWVUE1dZvdu68Yxtg5X4_Pv_QUfMpF6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223922631</pqid></control><display><type>article</type><title>MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>New England Journal of Medicine</source><creator>Lehman, Constance D ; Gatsonis, Constantine ; Kuhl, Christiane K ; Hendrick, R. Edward ; Pisano, Etta D ; Hanna, Lucy ; Peacock, Sue ; Smazal, Stanley F ; Maki, Daniel D ; Julian, Thomas B ; DePeri, Elizabeth R ; Bluemke, David A ; Schnall, Mitchell D</creator><creatorcontrib>Lehman, Constance D ; Gatsonis, Constantine ; Kuhl, Christiane K ; Hendrick, R. Edward ; Pisano, Etta D ; Hanna, Lucy ; Peacock, Sue ; Smazal, Stanley F ; Maki, Daniel D ; Julian, Thomas B ; DePeri, Elizabeth R ; Bluemke, David A ; Schnall, Mitchell D ; ACRIN Trial 6667 Investigators Group</creatorcontrib><description>Up to 10% of women with a diagnosis of unilateral breast cancer have cancer in the contralateral breast, despite negative clinical and mammographic examinations. This study investigated the use of MRI examination of the contralateral breast in women with a diagnosis of unilateral breast cancer and negative clinical and mammographic examinations. MRI detected occult cancer in the contralateral breast in about 3% of these women. All of the cancers were early stage, without evidence of spread to the lymph nodes or beyond. MRI detected occult cancer in the contralateral breast in about 3% of women with a diagnosis of unilateral breast cancer and negative clinical and mammographic examinations. A woman with unilateral breast cancer has an increased risk of having cancer in the contralateral breast. 1 – 6 In the 1990s, the role of mammography in improving the detection of contralateral cancers at the time of the initial diagnosis of breast cancer was firmly established; as compared with clinical breast examination alone, mammography resulted in a 1 to 3% increase in the number of cancers detected. 7 – 9 Despite normal findings on clinical and mammographic examination of the contralateral breast at the time of the initial breast-cancer diagnosis, however, contralateral cancer was subsequently detected in up to 10% of women. 1 , . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMoa065447</identifier><identifier>PMID: 17392300</identifier><identifier>CODEN: NEJMAG</identifier><language>eng</language><publisher>Boston, MA: Massachusetts Medical Society</publisher><subject>Biological and medical sciences ; Biopsy ; Breast - pathology ; Breast cancer ; Breast Neoplasms - diagnosis ; Breast Neoplasms - diagnostic imaging ; Breast Neoplasms - pathology ; Carcinoma in Situ - diagnosis ; Carcinoma, Ductal, Breast - diagnosis ; Female ; Follow-Up Studies ; General aspects ; Gynecology. Andrology. Obstetrics ; Humans ; Magnetic Resonance Imaging ; Mammary gland diseases ; Mammography ; Medical diagnosis ; Medical sciences ; Middle Aged ; NMR ; Nuclear magnetic resonance ; Predictive Value of Tests ; ROC Curve ; Sensitivity and Specificity ; Tumors</subject><ispartof>The New England journal of medicine, 2007-03, Vol.356 (13), p.1295-1303</ispartof><rights>Copyright © 2007 Massachusetts Medical Society. All rights reserved.</rights><rights>2007 INIST-CNRS</rights><rights>Copyright 2007 Massachusetts Medical Society.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c504t-2a7f7fca843f4a1d74013810c4f6e49afdf7a291bd39c21e74155aee5c087643</citedby><cites>FETCH-LOGICAL-c504t-2a7f7fca843f4a1d74013810c4f6e49afdf7a291bd39c21e74155aee5c087643</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMoa065447$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJMoa065447$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>314,776,780,2746,2747,26080,27901,27902,52357,54039</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18624985$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17392300$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lehman, Constance D</creatorcontrib><creatorcontrib>Gatsonis, Constantine</creatorcontrib><creatorcontrib>Kuhl, Christiane K</creatorcontrib><creatorcontrib>Hendrick, R. Edward</creatorcontrib><creatorcontrib>Pisano, Etta D</creatorcontrib><creatorcontrib>Hanna, Lucy</creatorcontrib><creatorcontrib>Peacock, Sue</creatorcontrib><creatorcontrib>Smazal, Stanley F</creatorcontrib><creatorcontrib>Maki, Daniel D</creatorcontrib><creatorcontrib>Julian, Thomas B</creatorcontrib><creatorcontrib>DePeri, Elizabeth R</creatorcontrib><creatorcontrib>Bluemke, David A</creatorcontrib><creatorcontrib>Schnall, Mitchell D</creatorcontrib><creatorcontrib>ACRIN Trial 6667 Investigators Group</creatorcontrib><title>MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>Up to 10% of women with a diagnosis of unilateral breast cancer have cancer in the contralateral breast, despite negative clinical and mammographic examinations. This study investigated the use of MRI examination of the contralateral breast in women with a diagnosis of unilateral breast cancer and negative clinical and mammographic examinations. MRI detected occult cancer in the contralateral breast in about 3% of these women. All of the cancers were early stage, without evidence of spread to the lymph nodes or beyond. MRI detected occult cancer in the contralateral breast in about 3% of women with a diagnosis of unilateral breast cancer and negative clinical and mammographic examinations. A woman with unilateral breast cancer has an increased risk of having cancer in the contralateral breast. 1 – 6 In the 1990s, the role of mammography in improving the detection of contralateral cancers at the time of the initial diagnosis of breast cancer was firmly established; as compared with clinical breast examination alone, mammography resulted in a 1 to 3% increase in the number of cancers detected. 7 – 9 Despite normal findings on clinical and mammographic examination of the contralateral breast at the time of the initial breast-cancer diagnosis, however, contralateral cancer was subsequently detected in up to 10% of women. 1 , . . .</description><subject>Biological and medical sciences</subject><subject>Biopsy</subject><subject>Breast - pathology</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - diagnosis</subject><subject>Breast Neoplasms - diagnostic imaging</subject><subject>Breast Neoplasms - pathology</subject><subject>Carcinoma in Situ - diagnosis</subject><subject>Carcinoma, Ductal, Breast - diagnosis</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>General aspects</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Mammary gland diseases</subject><subject>Mammography</subject><subject>Medical diagnosis</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Predictive Value of Tests</subject><subject>ROC Curve</subject><subject>Sensitivity and Specificity</subject><subject>Tumors</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpt0M9PFDEUwPGGYGRFb5xJY9STo_0105kjLqtiFk0ICeE0eXReZTYz7dJ2MPz3drNLMIYeXi-fvDZfQo44-8RZWX3-ufhx7oFVpVJ6j8x4KWWhFKv2yYwxURdKN_KAvIpxxfLhqnlJDriWjZCMzcj1-cUZXdzDMEHqvaPe0nSLdO5dCjBAwjzpl4AQE-0dvfIjOvqnT7f0Ag26NDzQ0x5-Ox-xe3RzcAbDa_LCwhDxze4-JJdfF5fz78Xy17ez-cmyMCVTqRCgrbYGaiWtAt5pxbisOTPKVqgasJ3VIBp-08nGCI5a8bIExNKwWldKHpIP27Xr4O8mjKkd-2hwGMChn2KrmeSaCZ7h2__gyk_B5a-1QuQcopIb9HGLTPAxBrTtOvQjhIeWs3aTu_03d-bHu53TzYjdE971zeD9DkA0MNiQ0_TxydWVUE1dZvdu68Yxtg5X4_Pv_QUfMpF6</recordid><startdate>20070329</startdate><enddate>20070329</enddate><creator>Lehman, Constance D</creator><creator>Gatsonis, Constantine</creator><creator>Kuhl, Christiane K</creator><creator>Hendrick, R. Edward</creator><creator>Pisano, Etta D</creator><creator>Hanna, Lucy</creator><creator>Peacock, Sue</creator><creator>Smazal, Stanley F</creator><creator>Maki, Daniel D</creator><creator>Julian, Thomas B</creator><creator>DePeri, Elizabeth R</creator><creator>Bluemke, David A</creator><creator>Schnall, Mitchell D</creator><general>Massachusetts Medical Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20070329</creationdate><title>MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer</title><author>Lehman, Constance D ; Gatsonis, Constantine ; Kuhl, Christiane K ; Hendrick, R. Edward ; Pisano, Etta D ; Hanna, Lucy ; Peacock, Sue ; Smazal, Stanley F ; Maki, Daniel D ; Julian, Thomas B ; DePeri, Elizabeth R ; Bluemke, David A ; Schnall, Mitchell D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c504t-2a7f7fca843f4a1d74013810c4f6e49afdf7a291bd39c21e74155aee5c087643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Biological and medical sciences</topic><topic>Biopsy</topic><topic>Breast - pathology</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - diagnosis</topic><topic>Breast Neoplasms - diagnostic imaging</topic><topic>Breast Neoplasms - pathology</topic><topic>Carcinoma in Situ - diagnosis</topic><topic>Carcinoma, Ductal, Breast - diagnosis</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>General aspects</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Mammary gland diseases</topic><topic>Mammography</topic><topic>Medical diagnosis</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Predictive Value of Tests</topic><topic>ROC Curve</topic><topic>Sensitivity and Specificity</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lehman, Constance D</creatorcontrib><creatorcontrib>Gatsonis, Constantine</creatorcontrib><creatorcontrib>Kuhl, Christiane K</creatorcontrib><creatorcontrib>Hendrick, R. Edward</creatorcontrib><creatorcontrib>Pisano, Etta D</creatorcontrib><creatorcontrib>Hanna, Lucy</creatorcontrib><creatorcontrib>Peacock, Sue</creatorcontrib><creatorcontrib>Smazal, Stanley F</creatorcontrib><creatorcontrib>Maki, Daniel D</creatorcontrib><creatorcontrib>Julian, Thomas B</creatorcontrib><creatorcontrib>DePeri, Elizabeth R</creatorcontrib><creatorcontrib>Bluemke, David A</creatorcontrib><creatorcontrib>Schnall, Mitchell D</creatorcontrib><creatorcontrib>ACRIN Trial 6667 Investigators Group</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lehman, Constance D</au><au>Gatsonis, Constantine</au><au>Kuhl, Christiane K</au><au>Hendrick, R. Edward</au><au>Pisano, Etta D</au><au>Hanna, Lucy</au><au>Peacock, Sue</au><au>Smazal, Stanley F</au><au>Maki, Daniel D</au><au>Julian, Thomas B</au><au>DePeri, Elizabeth R</au><au>Bluemke, David A</au><au>Schnall, Mitchell D</au><aucorp>ACRIN Trial 6667 Investigators Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2007-03-29</date><risdate>2007</risdate><volume>356</volume><issue>13</issue><spage>1295</spage><epage>1303</epage><pages>1295-1303</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><coden>NEJMAG</coden><abstract>Up to 10% of women with a diagnosis of unilateral breast cancer have cancer in the contralateral breast, despite negative clinical and mammographic examinations. This study investigated the use of MRI examination of the contralateral breast in women with a diagnosis of unilateral breast cancer and negative clinical and mammographic examinations. MRI detected occult cancer in the contralateral breast in about 3% of these women. All of the cancers were early stage, without evidence of spread to the lymph nodes or beyond. MRI detected occult cancer in the contralateral breast in about 3% of women with a diagnosis of unilateral breast cancer and negative clinical and mammographic examinations. A woman with unilateral breast cancer has an increased risk of having cancer in the contralateral breast. 1 – 6 In the 1990s, the role of mammography in improving the detection of contralateral cancers at the time of the initial diagnosis of breast cancer was firmly established; as compared with clinical breast examination alone, mammography resulted in a 1 to 3% increase in the number of cancers detected. 7 – 9 Despite normal findings on clinical and mammographic examination of the contralateral breast at the time of the initial breast-cancer diagnosis, however, contralateral cancer was subsequently detected in up to 10% of women. 1 , . . .</abstract><cop>Boston, MA</cop><pub>Massachusetts Medical Society</pub><pmid>17392300</pmid><doi>10.1056/NEJMoa065447</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 2007-03, Vol.356 (13), p.1295-1303
issn 0028-4793
1533-4406
language eng
recordid cdi_proquest_miscellaneous_70317021
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; New England Journal of Medicine
subjects Biological and medical sciences
Biopsy
Breast - pathology
Breast cancer
Breast Neoplasms - diagnosis
Breast Neoplasms - diagnostic imaging
Breast Neoplasms - pathology
Carcinoma in Situ - diagnosis
Carcinoma, Ductal, Breast - diagnosis
Female
Follow-Up Studies
General aspects
Gynecology. Andrology. Obstetrics
Humans
Magnetic Resonance Imaging
Mammary gland diseases
Mammography
Medical diagnosis
Medical sciences
Middle Aged
NMR
Nuclear magnetic resonance
Predictive Value of Tests
ROC Curve
Sensitivity and Specificity
Tumors
title MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T08%3A49%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MRI%20Evaluation%20of%20the%20Contralateral%20Breast%20in%20Women%20with%20Recently%20Diagnosed%20Breast%20Cancer&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Lehman,%20Constance%20D&rft.aucorp=ACRIN%20Trial%206667%20Investigators%20Group&rft.date=2007-03-29&rft.volume=356&rft.issue=13&rft.spage=1295&rft.epage=1303&rft.pages=1295-1303&rft.issn=0028-4793&rft.eissn=1533-4406&rft.coden=NEJMAG&rft_id=info:doi/10.1056/NEJMoa065447&rft_dat=%3Cproquest_cross%3E1246505991%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223922631&rft_id=info:pmid/17392300&rfr_iscdi=true